DeVita Jr VT, Chu E. A history of cancer chemotherapy. Cancer Res. 2008;68:8643–53.
Article
CAS
PubMed
Google Scholar
Chabner BA, Roberts Jr TG. Timeline: chemotherapy and the war on cancer. Nat Rev Cancer. 2005;5:65–72.
Article
CAS
PubMed
Google Scholar
Savage P, Stebbing J, Bower M, Crook T. Why does cytotoxic chemotherapy cure only some cancers? Nat Clin Pract Oncol. 2009;6:43–52.
Article
CAS
PubMed
Google Scholar
Savage P. Clinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential. BMC Cancer. 2015;15:11.
Article
PubMed
PubMed Central
Google Scholar
Wood ME, Vogel V, Ng A, Foxhall L, Goodwin P, Travis LB. Second malignant neoplasms: assessment and strategies for risk reduction. J Clin Oncol. 2012;30:3734–45.
Article
PubMed
Google Scholar
Mitchison TJ. The proliferation rate paradox in antimitotic chemotherapy. Mol Biol Cell. 2012;23:1–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gascoigne KE, Taylor SS. How do anti-mitotic drugs kill cancer cells? J Cell Sci. 2009;122:2579–85.
Article
CAS
PubMed
Google Scholar
Skipper H, Schabel F, Bell M, Thomson J, Johnson S. On the curability of experimental neoplasms. I. Amethopterin and mouse leukemias. Cancer Res. 1957;17:717–26.
CAS
PubMed
Google Scholar
Skipper H, Schabel F, Wilcox W. I. Experimental evaluation of potential anticancer agents. XIII On the criteria and kinetics associated with ‘curability’ of experimental leukemia. Cancer Chemother Rep. 1964;35:1–111.
CAS
PubMed
Google Scholar
Cohnheim J. Ueber entzündung und eiterung. Path Anat Physiol Klin Med. 1867;40:1.
Google Scholar
Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367:645–8.
Article
CAS
PubMed
Google Scholar
Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730–7.
Article
CAS
PubMed
Google Scholar
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100:3983–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene. 2004;23:7274–82.
Article
CAS
PubMed
Google Scholar
Hubbard SA, Friel AM, Kumar B, Zhang L, Rueda BR, Gargett CE. Evidence for cancer stem cells in human endometrial carcinoma. Cancer Res. 2009;69:8241–8.
Article
CAS
PubMed
Google Scholar
Li C, Lee CJ, Simeone DM. Identification of human pancreatic cancer stem cells. Methods Mol Biol. 2009;568:161–73.
Article
CAS
PubMed
Google Scholar
Chu P, Clanton DJ, Snipas TS, Lee J, Mitchell E, Nguyen ML, Hare E, Peach RJ. Characterization of a subpopulation of colon cancer cells with stem cell-like properties. Int J Cancer. 2009;124:1312–21.
Article
CAS
PubMed
Google Scholar
Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea--a paradigm shift. Cancer Res. 2006;66:1883–90.
Article
CAS
PubMed
Google Scholar
Vasiliou V, Vasiliou K, Nebert DW. Human ATP-binding cassette (ABC) transporter family. Hum Genomics. 2009;3:281–90.
Article
CAS
PubMed
PubMed Central
Google Scholar
Donnenberg VS, Donnenberg AD. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J Clin Pharmacol. 2005;45:872–7.
Article
CAS
PubMed
Google Scholar
Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst. 2008;100:672–9.
Article
CAS
PubMed
Google Scholar
Pardal R, Clarke MF, Morrison SJ. Cancer stem cells: a step toward the cure. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer. 2003;3:895–902.
Article
CAS
PubMed
Google Scholar
Boman BM, Wicha MS. Cancer stem cells: a step toward the cure. J Clin Oncol. 2008;26:2795–9.
Article
PubMed
Google Scholar
Odoux C, Fohrer H, Hoppo T, Guzik L, Stolz DB, Lewis DW, et al. A stochastic model for cancer stem cell origin in metastatic colon cancer. Cancer Res. 2008;68:6932–41.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70.
Article
CAS
PubMed
Google Scholar
Küppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med. 1999;341:1520–9.
Article
PubMed
Google Scholar
Küppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer. 2005;5:251–62.
Article
PubMed
Google Scholar
Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochem Biophys Acta. 1976;455:152–62.
Article
CAS
PubMed
Google Scholar
Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2:48–58.
Article
CAS
PubMed
Google Scholar
Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A. 1987;84:265–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Leonard GD, Fojo T, Bates SE. The role of ABC transporters in clinical practice. Oncologist. 2003;8:411–24.
Article
CAS
PubMed
Google Scholar
Fletcher JI, Haber M, Henderson MJ, Norris MD. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer. 2010;10:147–56.
Article
CAS
PubMed
Google Scholar
Gillet JP, Gottesman MM. Mechanisms of multidrug resistance in cancer. Methods Mol Biol. 2010;596:47–76.
Article
CAS
PubMed
Google Scholar
Tamaki A, Ierano C, Szakacs G, Robey RW, Bates SE. The controversial role of ABC transporters in clinical oncology. Essays Biochem. 2011;50:209–32.
Article
CAS
PubMed
Google Scholar
Callaghan R, Luk F, Bebawy M. Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy? Drug Metab Dispos. 2014;42:623–31.
Article
PubMed
PubMed Central
Google Scholar
Bunting KD. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells. 2002;20:11–20.
Article
CAS
PubMed
Google Scholar
An Y, Ongkeko WM. ABCG2: the key to chemoresistance in cancer stem cells? Expert Opin Drug Metab Toxicol. 2009;5:1529–42.
Article
CAS
PubMed
Google Scholar
Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001;7:1028–34.
Article
CAS
PubMed
Google Scholar
Abdullah LN, Chow EK. Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med. 2013;17(2):3.
Article
Google Scholar
Burger H, Foekens JA, Look MP, Meijer-van Gelder ME, Klijn JG, Wiemer EA, et al. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. Clin Cancer Res. 2003;9:827–36.
CAS
PubMed
Google Scholar
Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 2006;5:219–34.
Article
PubMed
Google Scholar
Sawicki WT, Kujawa M, Jankowska-Steifer E, Mystkowska ET, Hyc A, Kowalewski C. Temporal/spatial expression and efflux activity of ABC transporter, P-glycoprotein/Abcb1 isoforms and Bcrp/Abcg2 during early murine development. Gene Expr Patterns. 2006;6:738–46.
Article
CAS
PubMed
Google Scholar
Volpicelli ER, Lezcano C, Zhan Q, Girouard SD, Kindelberger DW, Frank MH, Frank NY, Crum CP, Murphy GF. The multidrug-resistance transporter ABCB5 is expressed in human placenta. Int J Gynecol Pathol. 2014;33:45–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood. 2002;99:507–12.
Article
CAS
PubMed
Google Scholar
van de Ven R, Oerlemans R, van der Heijden JW, Scheffer GL, de Gruijl TD, Jansen G, Scheper RJ. ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer. J Leukoc Biol. 2009;86:1075–87.
Article
PubMed
Google Scholar
Steinbach D, Wittig S, Cario G, Viehmann S, Mueller A, Gruhn B, et al. The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype. Blood. 2003;102:4493–8.
Article
CAS
PubMed
Google Scholar
Greaves W, Xiao L, Sanchez-Espiridion B, Kunkalla K, Dave KS, Liang CS, et al. Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols. J Hematol Oncol. 2012;5:47.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim JE, Singh RR, Cho-Vega JH, Drakos E, Davuluri Y, Khokhar FA, et al. Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma. Mod Pathol. 2009;22:1312–20.
Article
CAS
PubMed
Google Scholar
Hoellein A, Decker T, Bogner C, Oelsner M, Hauswald S, Peschel C, et al. Expression of multidrug resistance-associated ABC transporters in B-CLL is independent of ZAP70 status. J Cancer Res Clin Oncol. 2010;136:403–10.
Article
CAS
PubMed
Google Scholar
Turner JG, Gump JL, Zhang C, Cook JM, Marchion D, Hazlehurst L, et al. ABCG2 expression, function, and promoter methylation in human multiple myeloma. Blood. 2006;108:3881–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mayer F, Stoop H, Scheffer GL, Scheper R, Oosterhuis JW, Looijenga LH, Bokemeyer C. Molecular determinants of treatment response in human germ cell tumors. Clin Cancer Res. 2003;9:767–73.
CAS
PubMed
Google Scholar
Oliver RT, Mead GM, Rustin GJ, Joffe JK, Aass N, Coleman R, Gabe R, Pollock P, Stenning SP. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214). J Clin Oncol. 2011;29:957–62.
Article
CAS
PubMed
Google Scholar
Wang JC, Dick JE. Cancer stem cells: lessons from leukemia. Trends Cell Biol. 2005;15:494–501.
Article
CAS
PubMed
Google Scholar
Griffiths SD, Goodhead DT, Marsden SJ, Wright EG, Krajewski S, Reed JC, et al. Interleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis. J Exp Med. 1994;179:1789–97.
Article
CAS
PubMed
Google Scholar
Greaves MF. Stem cell origins of leukaemia and curability. Br J Cancer. 1993;67:413–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rehe K, Wilson K, Bomken S, Williamson D, Irving J, den Boer ML, et al. Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations. EMBO Mol Med. 2013;5:38–51.
Article
CAS
PubMed
Google Scholar
McClellan JS, Majeti R. The cancer stem cell model: B cell acute lymphoblastic leukaemia breaks the mould. EMBO Mol Med. 2013;5:7–9.
Article
CAS
PubMed
Google Scholar
Martinez-Climent JA, Fontan L, Gascoyne RD, Siebert R, Prosper F. Lymphoma stem cells: enough evidence to support their existence? Haematologica. 2010;95:293–302.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dogan A, Du MQ, Aiello A, Diss TC, Ye HT, Pan LX, Isaacson PG. Follicular lymphomas contain a clonally linked but phenotypically distinct neoplastic B-cell population in the interfollicular zone. Blood. 1998;91:4708–14.
CAS
PubMed
Google Scholar
Peacock CD, Wang Q, Gesell GS, Corcoran-Schwartz IM, Jones E, Kim J, et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci U S A. 2007;104:4048–53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jones RJ, Gocke CD, Kasamon YL, Miller CB, Perkins B, Barber JP, et al. Circulating clonotypic B cells in classic Hodgkin lymphoma. Blood. 2009;113:5920–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sita-Lumsden A, Short D, Lindsay I, Sebire NJ, Adjogatse D, Seckl MJ, Savage PM. Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000-2009. Br J Cancer. 2012;107:1810–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Alifrangis C, Agarwal R, Short D, Fisher RA, Sebire NJ, Harvey R, Savage PM, Seckl MJ. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis. J Clin Oncol. 2013;31:280–6.
Article
CAS
PubMed
Google Scholar
Weber M, Knoefler I, Schleussner E, Markert UR, Fitzgerald JS. HTR8/SVneo cells display trophoblast progenitor cell-like characteristics indicative of self-renewal, repopulation activity, and expression of “stemness-” associated transcription factors. Biomed Res Int. 2013;2013:243649.
Article
PubMed
PubMed Central
Google Scholar
Skakkebaek NE, Berthelsen JG, Giwercman A, Müller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl. 1987;10:19–28.
Article
CAS
PubMed
Google Scholar
Jørgensen N, Müller J, Jaubert F, Clausen OP, Skakkebaek NE. Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells. Histopathology. 1997;30:177–86.
Article
PubMed
Google Scholar
Jørgensen A, Nielsen JE, Almstrup K, Toft BG, Petersen BL, Rajpert-De ME. Dysregulation of the mitosis-meiosis switch in testicular carcinoma in situ. J Pathol. 2013;229:588–98.
Article
PubMed
Google Scholar
Masters JR, Koberle B. Curing metastatic cancer: lessons from testicular germ-cell tumours. Nat Rev Cancer. 2003;3:517–25.
Article
CAS
PubMed
Google Scholar
van Noesel MM, Versteeg R. Pediatric neuroblastomas: genetic and epigenetic ‘danse macabre’. Gene. 2004;325:1–15.
Article
PubMed
Google Scholar
Walton JD, Kattan DR, Thomas SK, Spengler BA, Guo HF, Biedler JL, et al. Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia. 2004;6:838–45.
Article
PubMed
PubMed Central
Google Scholar
Shukrun R, Pode-Shakked N, Pleniceanu O, Omer D, Vax E, Peer E, et al. Wilms’ tumor blastemal stem cells dedifferentiate to propagate the tumor bulk. Stem Cell Reports. 2014;3:24–33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Suvà ML, Riggi N, Stehle JC, Baumer K, Tercier S, Joseph JM, et al. Identification of cancer stem cells in Ewing’s sarcoma. Cancer Res. 2009;69:1776–81.
Article
PubMed
Google Scholar
Tu SM. Cancer: a “stem-cell” disease? Cancer Cell Int. 2013;13:40.
Article
PubMed
PubMed Central
Google Scholar
Schlissel MS, Kaffer CR, Curry JD. Leukemia and lymphoma: a cost of doing business for adaptive immunity. Genes Dev. 2006;20:1539–44.
Article
CAS
PubMed
Google Scholar
Kikushige Y, Ishikawa F, Miyamoto T, Shima T, Urata S, Yoshimoto G, et al. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell. 2011;20:246–59.
Article
CAS
PubMed
Google Scholar
Stovall TG, Ling FW, Gray LA. Single-dose methotrexate for treatment of ectopic pregnancy. Obstet Gynecol. 1991;77:754–7.
CAS
PubMed
Google Scholar
Christensen TB, Daugaard G, Geertsen PF, von der Maase H. Effect of chemotherapy on carcinoma in situ of the testis. Ann Oncol. 1998;9:657–60.
Article
CAS
PubMed
Google Scholar
Dudakov JA, Goldberg GL, Reiseger JJ, Vlahos K, Chidgey AP, Boyd RL. Sex steroid ablation enhances hematopoietic recovery following cytotoxic antineoplastic therapy in aged mice. J Immunol. 2009;183:7084–94.
Article
CAS
PubMed
Google Scholar